These observations regarding early and chronic HS lesions support the important role of both IL-17A and IL-17F in the pathogenesis of HS and further corroborate the hypothesis that elevated IL-1 may partly explain the high expression of IL-17F in HS lesions [39]. This evidence concerns the gene IL17F and histiocytic sarcoma.